“cancer” Archives

in
Entry Author Date Location
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Around Texas: Joseph Kopser, Mark Cuban, REVtech, Founder Institute 05/24/17 Texas
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Envision the Future: Request Your Invite to Our Napa Summit June 8-9 05/22/17 National
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Kite CAR-T Death: An Unwelcome Mystery as FDA Mulls Approval 05/08/17 National
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
New San Diego Biotech Looks to Open Way for Anti-Cancer Drugs 05/03/17 San Diego
Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer 05/01/17 San Diego
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
Becton Dickinson Aims Beyond Diabetes with $24B Bard Deal 04/24/17 New York
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials 04/13/17 San Diego
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More 04/07/17 National
EOW Reading List: AI Diagnosticians, Musk’s Warnings, Mnuchin’s Radar 04/06/17 Seattle
First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals 04/06/17 San Diego
Gedeon Richter Gets Ex-U.S. Rights for Evestra Urological Product 04/06/17 Texas
Arivale and Scripps Leaders to Chat at April 19 Xconomy Forum 04/06/17 San Diego
Speaker Lineup Takes Shape for “What’s Hot in Cancer Immunotherapy 2017” 04/04/17 Seattle
Stealthy San Diego-based Viracta Steps Into Light with $18.5M 04/04/17 San Diego
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
MD Anderson’s Hicks Named Interim President After DePinho Resignation 03/17/17 Texas
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
Biden’s Comments on Challenges in Cancer Care Highlight SXSW Talk 03/13/17 Texas
Page 2 of 67 « previous page · next page »